These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
126 related items for PubMed ID: 3121357
1. Activation of murine CD8+ lymphocytes: two distinct signals regulate c-myc and interleukin 2 receptor RNA expression. Hardt C. Eur J Immunol; 1987 Dec; 17(12):1711-7. PubMed ID: 3121357 [Abstract] [Full Text] [Related]
4. Regulation of interleukin 2 (IL2) receptor expression: IL2 as an inducing signal for the expression of its own receptor on a murine T helper cell line. Bismuth G, Moreau JL, Sommé G, Duphot M, Dautry-Varsat A, Robb RJ, Théze J. Eur J Immunol; 1985 Jul; 15(7):723-7. PubMed ID: 2408903 [Abstract] [Full Text] [Related]
8. Growth-dependent variation of major histocompatibility complex (MHC) restriction and expression of Ly-2 and CD3/alpha/beta T cell receptor in cloned cytotoxic T cells. Weltzien HU, Kempkes B, Studer R, Melchers I, Eichmann K. Eur J Immunol; 1988 Mar; 18(3):431-7. PubMed ID: 2965649 [Abstract] [Full Text] [Related]
10. Signal requirements for the in vitro differentiation of cytotoxic T lymphocytes (CTL): distinct soluble mediators promote preactivation of CTL-precursors, clonal growth and differentiation into cytotoxic effector cells. Hardt C, Diamantstein T, Wagner H. Eur J Immunol; 1985 May; 15(5):472-8. PubMed ID: 3158532 [Abstract] [Full Text] [Related]
12. Decreased proliferation, interleukin 2 synthesis, and interleukin 2 receptor expression are accompanied by decreased mRNA expression in phytohemagglutinin-stimulated cells from elderly donors. Nagel JE, Chopra RK, Chrest FJ, McCoy MT, Schneider EL, Holbrook NJ, Adler WH. J Clin Invest; 1988 Apr; 81(4):1096-102. PubMed ID: 3127423 [Abstract] [Full Text] [Related]
13. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells. Herrmann T, Maryanski JL, Romero P, Fleischer B, MacDonald HR. J Immunol; 1990 Feb 15; 144(4):1181-6. PubMed ID: 1968075 [Abstract] [Full Text] [Related]
15. T-cells infiltrating renal cell carcinoma display a poor proliferative response even though they can produce interleukin 2 and express interleukin 2 receptors. Alexander JP, Kudoh S, Melsop KA, Hamilton TA, Edinger MG, Tubbs RR, Sica D, Tuason L, Klein E, Bukowski RM. Cancer Res; 1993 Mar 15; 53(6):1380-7. PubMed ID: 8443817 [Abstract] [Full Text] [Related]
17. Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and nonmitogenic T3 and T11 activation signals. Shipp MA, Reinherz EL. J Immunol; 1987 Oct 01; 139(7):2143-8. PubMed ID: 2821108 [Abstract] [Full Text] [Related]
18. T cell-accessory cell interactions that initiate allospecific cytotoxic T lymphocyte responses: existence of both Ia-restricted and Ia-unrestricted cellular interaction pathways. Singer A, Kruisbeek AM, Andrysiak PM. J Immunol; 1984 May 01; 132(5):2199-209. PubMed ID: 6201534 [Abstract] [Full Text] [Related]
19. Cellular oncogenes and lymphocyte activation. Schneider-Schaulies J, Knauer R, Schimpl A, Wecker E. Behring Inst Mitt; 1987 Jun 01; (81):110-9. PubMed ID: 3115245 [Abstract] [Full Text] [Related]
20. Unique pattern of interleukin 2 receptor expression by lymphocytes in response to anti-Leu 4 monoclonal antibody: relationship to monocyte accessory cell function. Prince HE, John JK. Diagn Immunol; 1986 Jun 01; 4(5):241-6. PubMed ID: 3098490 [Abstract] [Full Text] [Related] Page: [Next] [New Search]